Swedish Orphan Biovitrum AB (B6E.SG)
Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
As of 12:55PM CEST. Market open.
| Previous close | 22.86 |
| Open | 22.82 |
| Bid | 23.28 x 100000 |
| Ask | 23.38 x 100000 |
| Day's range | 22.82 - 23.26 |
| 52-week range | 16.10 - 26.06 |
| Volume | |
| Avg. volume | 12 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting (the "Meeting"), to be held on Tuesday, 14 May 2024 at 15.00 at IVA Konferenscenter, Grev Turegatan 16, Stockholm, Sweden.
- PR Newswire
Sobi publishes Annual and sustainability report for 2023
Swedish Orphan Biovitrum AB (publ) (Sobi®) today published its Annual and sustainability report for 2023. Inspired by caring and powered by science, the integrated report summarises business and strategy, financial performance, and work on sustainability.
- PR Newswire
Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter 2023.
© 2024 Yahoo. All rights reserved.